Please login to the form below

Wilmington Healthcare appoints new Account Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

In his new post, Gareth will be overseeing a number of key accounts across the Wilmington Healthcare portfolio and ensuring that the relevant specialist teams meet their objectives.

Gareth who has worked in sales and marketing roles in the healthcare industry for nearly 30 years, joins Wilmington Healthcare from Cello Health Consulting Ltd, where he was a consultant.

Prior to that, Gareth spent nearly 10 years at Novartis Pharmaceuticals UK Limited, where he held a number of different roles, including Marketing Manager and Franchise Lead for the company’s transplantation portfolio. His final post at the company was Brand Lead, Ophthalmology.   Before joining Novartis, Gareth held senior sales and product manager positions at Gilead Sciences Ltd in their anti-infective franchise.

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in sales and marketing roles in the healthcare industry for nearly 30 years, Gareth Thurston brings a wealth of experience to his new job.

“He will play an important role in supporting our clients to achieve greater success, whilst helping our business to continue to go from strength to strength. We are very pleased to welcome him to our team.” 


Gareth Thurston

26th September 2017

Share

Tags

Company Details

Wilmington Healthcare

01268 495600

Contact Website

Address:
Beechwood House
2-3 Commercial Way
Christy Close
Southfields
Basildon
SS15 6EF
United Kingdom

Latest content on this profile

Wilmington Healthcare appoints new Account Director
Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.
Wilmington Healthcare
What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?
Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach
Wilmington Healthcare
How will the NHS’s new medicines savings drive affect pharma?
Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets
Wilmington Healthcare
Launch of the HSJ Partnership Awards: a programme for inspirational organisations helping to transform the NHS
New Awards will recognise the many private sector organisations who partner with the NHS to deliver improved patient outcomes and cost-effective care
Wilmington Healthcare
How can pharma help the NHS capitalise on its data?
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
Wilmington Healthcare
How can pharma engage with Accountable Care Systems?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain how pharma can add value across care pathways
Wilmington Healthcare